These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4401051)

  • 81. [Initial treatment of essential hypertension. Combination of a thiazide with methyldopa, and a beta-blocking agent with hydralazine].
    Lindholm J; Hansen OP; Hansen M
    Ugeskr Laeger; 1978 May; 140(19):1088-91. PubMed ID: 26134
    [No Abstract]   [Full Text] [Related]  

  • 82. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P; Bühler FR; Kiowski W; Bolli P; Bertel O
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):380-5. PubMed ID: 40887
    [No Abstract]   [Full Text] [Related]  

  • 83. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102. PubMed ID: 5438435
    [No Abstract]   [Full Text] [Related]  

  • 84. [Docidrazin. Long-term observation with a 3-component antihypertensive agent].
    Degenring FH
    ZFA (Stuttgart); 1983 Mar; 59(8):476-8. PubMed ID: 6407227
    [No Abstract]   [Full Text] [Related]  

  • 85. Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy.
    Hollenberg NK
    Medicographia; 1987; 9(3):2-4. PubMed ID: 11539067
    [No Abstract]   [Full Text] [Related]  

  • 86. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Antihypertensive therapy in pregnancy].
    Richter R
    Gynakologe; 1982 Sep; 15(3):148-50. PubMed ID: 6129181
    [No Abstract]   [Full Text] [Related]  

  • 88. Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.
    Velasco M; O'Malley K; Robie NW; Wells J; Israili ZH; McNay JL
    Clin Pharmacol Ther; 1974 Dec; 16(6):1031-8. PubMed ID: 4373024
    [No Abstract]   [Full Text] [Related]  

  • 89. [Advances in the treatment of hypertension].
    Januszewicz W; Sznajderman M
    Pol Tyg Lek; 1977 Nov; 32(47):1853-5. PubMed ID: 23521
    [No Abstract]   [Full Text] [Related]  

  • 90. Pharmacokinetic studies of minoxidil.
    Gottlieb TB; Thomas RC; Chidsey CA
    Clin Pharmacol Ther; 1972; 13(3):436-41. PubMed ID: 5026381
    [No Abstract]   [Full Text] [Related]  

  • 91. Antihypertensive drugs: clinical pharmacology and therapeutic use.
    Wollam GL; Gifford RW; Tarazi RC
    Drugs; 1977 Dec; 14(6):420-60. PubMed ID: 23284
    [No Abstract]   [Full Text] [Related]  

  • 92. [Treatment of arterial hypertension with propranolol].
    Cristodorescu R; Costea M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(1):17-24. PubMed ID: 16326
    [No Abstract]   [Full Text] [Related]  

  • 93. Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
    Pedersen EB; Kornerup HJ
    Eur J Clin Pharmacol; 1977 Oct; 12(2):93-6. PubMed ID: 923630
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Double-blind comparison of minoxidil and hydrallazine in severe hypertension.
    Connor G; Wilburn RL; Bennett CM
    Clin Sci Mol Med Suppl; 1976 Dec; 3():593s-595s. PubMed ID: 140037
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J; Messerli F; Hodler J
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract]   [Full Text] [Related]  

  • 96. Echocardiographic assessment of the effect of an antihypertensive regimen on left ventricular performance.
    Moyer JP; Pittman AW; Belasco RN; Woods JW
    Am J Cardiol; 1979 Mar; 43(3):594-9. PubMed ID: 420108
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Propranolol as an antihypertensive agent.
    Prichard BN
    Am Heart J; 1970 Jan; 79(1):128-33. PubMed ID: 4391325
    [No Abstract]   [Full Text] [Related]  

  • 98. Comparative antihypertensive effects of a diuretic, reserpine, and hydralazine in the spontaneously hypertensive rat.
    Freis ED; Notargiacomo A; Burris JF
    Proc Soc Exp Biol Med; 1981 Mar; 166(3):364-8. PubMed ID: 7208495
    [No Abstract]   [Full Text] [Related]  

  • 99. Primary hypertension refractory to triple drug treatment - a study on central and peripheral hemodynamics.
    Andersson O; Hansson L; Sivertsson R
    Acta Med Scand Suppl; 1979; 625():19-21. PubMed ID: 285571
    [No Abstract]   [Full Text] [Related]  

  • 100. Plasma volume changes with long-term beta-adrenergic blockade.
    Tarazi RC; Frohlich ED; Dustan HP
    Am Heart J; 1971 Dec; 82(6):770-6. PubMed ID: 4399785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.